Euan Reid
LightNews LightNews
euanreid.pharmsky.app
Euan Reid
@euanreid.pharmsky.app
180 followers 240 following 150 posts
Pharmacist 🏴󠁧󠁢󠁳󠁣󠁴󠁿 #Pharmsky
Posts Replies Media Videos
euanreid.pharmsky.app
Hospital at Home | Guiding principles for service development 🏴󠁧󠁢󠁳󠁣󠁴󠁿

www.healthcareimprovementscotland.scot/wp-content/u...
November 2, 2025 at 8:04 AM
euanreid.pharmsky.app
Isotretinoin - updates to prescribing guidance and survey of services | Drug Safety Update

#Pharmsky

www.gov.uk/drug-safety-...
Overview of Measures The Medicines and Healthcare products Regulatory Agency (MHRA) has reviewed the impact of the implementation of the recommendations advised by the Commission on Human Medicines (CHM) who were informed by its Isotretinoin Expert Working Group (IEWG) and Isotretinoin Implementation Advisory Expert Working Group (IIAEWG) in 2023. The CHM has endorsed changes to the isotretinoin prescribing guidance of the IIAEWG and an addendum to the IIAEWG report has been published to amend and clarify previous advice, regarding follow-up consultations, pregnancy testing and sexual function monitoring. In addition, the CHM agreed an effective approach is required to monitor the adherence to risk minimisation measures going forward, whilst supporting patient access to treatment across all age groups.  As such, the MHRA seeks to undertake a survey of services where isotretinoin is prescribed to support its safe prescribing. Both NHS and private services which prescribe isotretinoin for the treatment of acne will be asked to complete a baseline survey by 16 November 2025. This data will be used to inform the CHM recommendations on the regulatory requirements of isotretinoin, whilst supporting patient access to treatment across all age groups. It will also provide baseline information to monitor adherence to risk minimisation measures, to ensure the continuation of safe prescribing.
October 29, 2025 at 4:22 PM
euanreid.pharmsky.app
AN OVERVIEW OF THE SOCIAL DETERMINANTS OF HEALTH IN SCOTLAND: THE COLLABORATION
FOR HEALTH EQUITY IN SCOTLAND

www.instituteofhealthequity.org/resources-re...
October 15, 2025 at 8:35 AM
euanreid.pharmsky.app
AGA Clinical Practice Guideline on Management of Gastroparesis
#Pharmsky

www.gastrojournal.org/article/S001...
October 11, 2025 at 7:38 AM
euanreid.pharmsky.app
Empowering patients and upskilling clinicians to tackle overprescribing

#Pharmsky

thehealthinnovationnetwork.co.uk/news/empower...
The programme has successfully engaged with over 12,000 healthcare professionals to support them with the skills and confidence to tackle overprescribing, delivered 124 communities of practice across the country, and co-developed vital resources to empower patients in conversations about their medicines. The programme was launched in April 2022 to address the urgent and growing challenge of problematic polypharmacy – when a patient is taking multiple medicines, some of which may no longer be necessary or could be causing harm. The scale of the issue is considerable. In March 2025, more than 718,000 people aged 65 and over in England were taking 10 or more medicines, a figure projected to exceed 1.1 million by 2035 without effective intervention. To address this, the programme, which engaged all 42 Integrated Care Boards (ICBs) across England, was built on a core three-pillar approach: Population health management: using NHS data to identify patients most at risk of harm from their medicines. Education and training: upskilling the primary care workforce to confidently and safely stop unnecessary medicines. Changing public behaviour: co-producing resources to support patients in having better, shared-decision-making conversations about their medicines. A range of Polypharmacy education and learning events reached 12,891 health and care professionals, including 1,301 GPs and pharmacists who completed the Polypharmacy Action Learning Sets (ALS) course, which has been exceptionally well-received: 99% of ALS participants said they would recommend the course to colleagues. 83% reported making changes to their practice as a result, including increasing shared decision-making with patients and actively stopping medicines. Participants highly valued the interactive, peer-to-peer discussions and specialist input, particularly from geriatricians. One GP described the course as transformative, saying: “This will change my practice more than any learning event I have ever done.”
October 1, 2025 at 3:29 PM
euanreid.pharmsky.app
Five years of a greener NHS: progress and forward look.

"NHS Carbon Footprint emissions have already decreased by 14% since the strategy to deliver a net zero NHS was published, and over 68% since 1990".

#Pharmsky #Medsky

www.england.nhs.uk/long-read/fi...
In 2020, the NHS became the first healthcare system in the world to commit to becoming net zero. This commitment was made in response to the evidence that climate change is no longer a distant threat but is already affecting the health and wellbeing of patients and communities across the country. The benefits of taking action not only reduce the future impacts of climate change, but also deliver more immediate benefits for health. Such action sits alongside the urgent need to adapt the NHS to the impacts of climate change, which will be felt hardest by the most vulnerable in our society, and will place significant strain on NHS infrastructure, staff and finances. Healthcare in England is estimated to contribute between 4% and 5% of national emissions, and around 40% of all emissions generated by the public sector. Not only does the NHS have a clear responsibility to minimise its environmental impact, building a more sustainable NHS offers a unique opportunity to deliver better patient care while minimising cost and impact on future services. NHS England committed to regular reviews of progress, and this report is the first assessment. To support this work, the NHS Net Zero Expert Panel – comprising global leaders and specialists in environmental sustainability, healthcare and carbon analytics – was convened to provide guidance on the next stages of this critical journey. Despite the challenges over recent years, NHS staff have demonstrated extraordinary dedication. They have embraced sustainability principles, implemented impactful solutions and driven change. Thanks to their efforts, NHS Carbon Footprint emissions have already decreased by 14% since the strategy to deliver a net zero NHS was published, and over 68% since 1990 – an impressive achievement given the context, and a reflection of their commitment.
October 1, 2025 at 3:21 PM
euanreid.pharmsky.app
Palliative Care Matters for All
Palliative care strategy (2025–30) 🏴󠁧󠁢󠁳󠁣󠁴󠁿

Working together to improve life, health and care for people of all ages living with life shortening conditions or dying in Scotland.

www.gov.scot/publications...
September 17, 2025 at 3:25 PM
euanreid.pharmsky.app
Oral methylcobalamin significantly lowered the severity of hand-foot syndrome by reducing the incidence of grade ≥2 symptoms without unexpected safety concerns in women with HER2 negative early breast cancer who were receiving adjuvant capecitabine treatment.

#Pharmsky

www.bmj.com/content/390/...
September 11, 2025 at 9:10 PM
euanreid.pharmsky.app
Chronic heart failure in adults: diagnosis and management | NICE guideline 106 (updated 2025).

Core Treatments for heart failure.
#Pharmsky
September 4, 2025 at 6:36 PM
euanreid.pharmsky.app
Chronic heart failure in adults: diagnosis and management | NICE guideline 106 (updated 2025).

Specialist heart failure pharmacists as part of the heart failure MDT - new recommendation.
#Pharmsky

@nicecomms.bsky.social

www.nice.org.uk/guidance/ng106
September 4, 2025 at 6:35 PM
euanreid.pharmsky.app
Home blood pressure monitoring (HBPM) should be available for patients with suspected and diagnosed hypertension. Only upper arm cuff monitors that have been validated by the British & Irish Hypertension Society should be used to ensure accuracy of the monitors.

🏴󠁧󠁢󠁳󠁣󠁴󠁿 SHTG

shtg.scot/our-advice/h...
September 1, 2025 at 7:13 PM
euanreid.pharmsky.app
Quality Prescribing for Chronic Pain 2026-2029 | Consultation closes 31 October 2025 🏴󠁧󠁢󠁳󠁣󠁴󠁿
#Pharmsky

www.gov.scot/publications...
September 1, 2025 at 6:12 PM
euanreid.pharmsky.app
SGLT2 inhibitor use is associated with improved outcomes in very elderly patients with heart failure and high comorbidity burden.
#Pharmsky #Medsky

www.ahajournals.org/doi/10.1161/...
August 25, 2025 at 8:27 AM
euanreid.pharmsky.app
Pharmacist interventions reduce all-cause and HF hospitalisations, underscoring their role in alleviating HF's clinical burden. Prioritising their integration into multidisciplinary teams is essential to advance HF care.
#Pharmsky

bpspubs.onlinelibrary.wiley.com/doi/10.1002/...
August 25, 2025 at 8:11 AM
euanreid.pharmsky.app
GLP-1 medicines for weight loss and diabetes: what you need to know
@mhragovuk.bsky.social

#Pharmsky

www.gov.uk/government/p...
August 21, 2025 at 9:10 PM
euanreid.pharmsky.app
This survey of Scottish GPs provides further evidence that the key aims of the 2018 GP contract have not been realised and, despite the rapid increase in the MDT workforce, the majority of GPs reported no decrease in workload.
bjgp.org/content/75/7...
August 21, 2025 at 8:52 PM
euanreid.pharmsky.app
Extend medicines responsibilities for allied health professions - paramedics, physiotherapists, operating department practitioners and diagnostic radiographers.

Consultation closes on 28 October 2025
#Pharmsky

www.gov.uk/government/c...
August 7, 2025 at 6:58 PM
euanreid.pharmsky.app
Retrospectively collected real-world data of ∼2700 patients with severe asthma from five European countries suggest that dupilumab may be more effective in reducing exacerbations and oral corticosteroid use versus omalizumab, benralizumab or mepolizumab.

publications.ersnet.org/content/erjo...
August 6, 2025 at 9:09 PM
euanreid.pharmsky.app
All Wales adult asthma management and prescribing guideline - August 2025 update
#Pharmsky

awttc.nhs.wales/medicines-op...
August 6, 2025 at 8:26 PM
euanreid.pharmsky.app
ABPI - Bringing healthcare home: A blueprint for collaborative clinical homecare
www.abpi.org.uk/publications...
August 5, 2025 at 9:55 PM
euanreid.pharmsky.app
Primary Care Phased Investment Programme – evaluation update: July 2025
www.healthcareimprovementscotland.scot/publications...
August 5, 2025 at 9:53 PM
euanreid.pharmsky.app
National therapeutic indicators (NTI) data visualisation
Data to March 2025
#Pharmsky

www.publichealthscotland.scot/publications...
July 30, 2025 at 6:53 PM
euanreid.pharmsky.app
Healthy life expectancy in Scotland now 60yrs for females and below 60yrs for males (near a ten-year low).

www.nrscotland.gov.uk/publications...
July 30, 2025 at 6:10 PM
euanreid.pharmsky.app
The All-Party Parliamentary Group (APPG) on Pharmacy has published its landmark report into medicines shortages in England, further revealing the scale and severity of the issues facing patients, pharmacists and the wider NHS.
#Pharmsky

www.pharmacyappg.co.uk/news
July 8, 2025 at 10:00 PM
euanreid.pharmsky.app
Shortage of bumetanide 1mg tablets - National Patient Safety Alert
www.cas.mhra.gov.uk/ViewandAckno...
#Pharmsky #Medsky
July 4, 2025 at 9:12 AM